KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Issued
Ratios

Gilead Sciences (GILD) Shares Issued (2016 - 2025)

Gilead Sciences' Shares Issued history spans 17 years, with the latest figure at $32.0 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 81.5% year-over-year to $32.0 million; the TTM value through Dec 2025 reached $408.0 million, down 3.32%, while the annual FY2025 figure was $408.0 million, 3.32% down from the prior year.
  • Shares Issued reached $32.0 million in Q4 2025 per GILD's latest filing, down from $97.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $252.0 million in Q1 2025 to a low of $3.0 million in Q2 2022.
  • Average Shares Issued over 5 years is $77.0 million, with a median of $70.0 million recorded in 2021.
  • Peak YoY movement for Shares Issued: skyrocketed 1366.67% in 2022, then tumbled 85.23% in 2023.
  • A 5-year view of Shares Issued shows it stood at $12.0 million in 2021, then surged by 1366.67% to $176.0 million in 2022, then crashed by 85.23% to $26.0 million in 2023, then soared by 565.38% to $173.0 million in 2024, then crashed by 81.5% to $32.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Shares Issued are $32.0 million (Q4 2025), $97.0 million (Q3 2025), and $27.0 million (Q2 2025).